Study Shows Improved Outcomes in CABG Patients With INVOS

Somanetics has announced that results of a clinical study showed that avoidance of cerebral oxygen desaturations in actively managed diabetic coronary artery bypass graft (CABG) patients using Somanetics' INVOS Cerebral Oximeter brain oxygen monitoring system was associated with significantly improved clinical outcomes, to the level of nondiabetic patients.

The study analyzed outcomes of two CABG patient groups, diabetic and nondiabetic, which were monitored via the INVOS. Diabetic patients in the control group had, as expected, worse clinical outcomes and lower brain oxygen saturation values, than nondiabetic patients in that group.

Diabetic patients who were monitored with the INVOS System required shorter ventilation (nine hours versus 30), shorter stays in the intensive care unit (30 hours versus 69 hours) and shorter hospital stays (5.5 days versus 8.4 days) than diabetic patients in the control group. There was no difference in brain oxygen levels in the diabetic and nondiabetic patients in the intervention group, indicating that INVOS-prompted medical interventions kept brain blood oxygen saturation at adequate levels and helped diabetic patients achieve the same clinical outcomes as their nondiabetic peers.